Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL118899 | 0.84 | — | — | |
| SCHEMBL6739890 | 0.84 | — | — | |
| Isobutyramide SCHEMBL9732728 | 0.81 | TSHR (0.35) | TSHR | |
| Water SCHEMBL29412656 | 0.81 | — | — | |
| Dimethylformamide SCHEMBL3284756 | 0.75 | TSHR (0.60) | TSHRUSP2ALOX15 | |
| Benzene SCHEMBL5152353 | 0.75 | HTT (0.38) | — | |
| Dimethylformamide SCHEMBL1927321 | 0.73 | TSHR (1.00) | TSHRUSP2ALOX15 | |
| Dimethylformamide SCHEMBL10141201 | 0.73 | — | — | |
| Dimethylformamide SCHEMBL5 | 0.73 | — | — | |
| Dimethylformamide SCHEMBL1332179 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220024899-A1 | BI-FUNCTIONAL NANOHYBRIDS | SON (FR) | 2022-01-27 | — | — | US | disclosed |
| EP-3897977-A1 | BI-FUNCTIONAL NANOHYBRIDS | SON (FR) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020127644-A1 | BI-FUNCTIONAL NANOHYBRIDS | UNIVERSITE DE BOURGOGNE (FR) | 2020-06-25 | — | — | WO | disclosed |
| CN-107107546-B | Moisture-permeability waterproof fabric and its manufacturing method | 阿莫绿色技术有限公司 | 2019-11-05 | — | — | CN | disclosed |
| CN-108884058-A | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | 阿奇克斯制药公司 | 2018-11-23 | — | — | CN | disclosed |
| CN-108831999-A | A kind of preparation method of accuracy controlling perovskite thin film crystallite dimension | 南京邮电大学 | 2018-11-16 | — | — | CN | disclosed |
| CN-108832003-A | A method of improving perovskite solar cell photoelectric transfer efficiency | 南京邮电大学 | 2018-11-16 | — | — | CN | disclosed |
| CN-108780843-A | Semiconductor element, its manufacturing method, wireless communication device and sensor | 东丽株式会社 | 2018-11-09 | — | — | CN | disclosed |
| CN-104984372-B | Radioconjugation method | 通用电气健康护理有限公司 | 2018-11-09 | — | — | CN | disclosed |
| CN-106573898-B | Treat and prevent hepatitis b virus infected new pyridazinone and triazinone | 豪夫迈·罗氏有限公司 | 2018-11-09 | — | — | CN | disclosed |
| US-20020115685-A1 | Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them | SANOFI-AVENTIS (FR) | 2002-08-22 | — | — | US | disclosed |
| US-6420375-B1 | ANTITUMOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-16 | — | — | US | disclosed |
| WO-2002018327-A2 | GUANIDINOBENZAMIDES AS MC4-R AGONISTS | CHIRON CORPORATION (US) | 2002-03-07 | — | — | WO | disclosed |
| CN-1072210-C | 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors | SANOFI SYNTHELABO (FR) | 2001-10-03 | — | — | CN | disclosed |
| EP-0787115-B1 | PROCESS FOR PRODUCING DERIVATIVES OF 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINE | SANOCHEMIA PHARMAZEUTIKA AG (AT) | 2000-01-05 | — | — | EP | disclosed |
| CN-1038748-C | Method for preparing sulfonamide fibrinogen receptor antagonists | MERCK & CO INC (US) | 1998-06-17 | — | — | CN | disclosed |
| US-5284661-A | 4-Oxo-7-(biphenyl-4-yl)thieno(2,3-b)pyridines as antagonist of angiotensin II; hypertensive agents, cardiovascular disorders and strokes | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-02-08 | — | — | US | disclosed |
| US-5128366-A | Enzyme inhibitors, anticholesterol | SHINOGI & CO., LTD. (JP) | 1992-07-07 | — | — | US | disclosed |
| US-5095139-A | Fungicides | CIBA-GEIGY CORPORATION (US) | 1992-03-10 | — | — | US | disclosed |
| EP-0246795-A2 | Synthetic natriuretic peptides | ADVANCED PEPTIDE DEVELOPMENT LIMITED (GB) | 1987-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115685-A1 | Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them | CYP2C9, ADRM1, ADRA1D | TSHR 2697/4885USP2 2707/4885ALOX15 1768/4885 |
| US-20220024899-A1 | BI-FUNCTIONAL NANOHYBRIDS | MPO, DNMT1, CAT | TSHR 4185/4885USP2 587/4885ALOX15 3155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.